These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23716983)

  • 21. Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer.
    Ling ZQ; Li P; Ge MH; Hu FJ; Fang XH; Dong ZM; Mao WM
    Dig Dis Sci; 2011 Oct; 56(10):2992-3004. PubMed ID: 21674174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helicobacter pylori induces promoter hypermethylation and downregulates gene expression of IRX1 transcription factor on human gastric mucosa.
    Guo XB; Guo L; Zhi QM; Ji J; Jiang JL; Zhang RJ; Zhang JN; Zhang J; Chen XH; Cai Q; Li JF; Yan M; Gu QL; Liu BY; Zhu ZG; Yu YY
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1685-90. PubMed ID: 21649733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients.
    Pierini S; Jordanov SH; Mitkova AV; Chalakov IJ; Melnicharov MB; Kunev KV; Mitev VI; Kaneva RP; Goranova TE
    Head Neck; 2014 Aug; 36(8):1103-8. PubMed ID: 23804521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inactivation of COX-2, HMLH1 and CDKN2A gene by promoter methylation in gastric cancer: relationship with histological subtype, tumor location and Helicobacter pylori genotype.
    Alves MK; Ferrasi AC; Lima VP; Ferreira MV; de Moura Campos Pardini MI; Rabenhorst SH
    Pathobiology; 2011; 78(5):266-76. PubMed ID: 21849808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant DNA methylation of P16, MGMT, hMLH1 and hMSH2 genes in combination with the MTHFR C677T genetic polymorphism in gastric cancer.
    Xiong HL; Liu XQ; Sun AH; He Y; Li J; Xia Y
    Asian Pac J Cancer Prev; 2013; 14(5):3139-42. PubMed ID: 23803092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA variants in Helicobacter pylori infected patients with chronic gastritis, dysplasia and gastric cancer.
    Hnatyszyn A; Szalata M; Skrzypczak-Zielinska M; Wielgus K; Stanczyk J; Dziuba I; Mikstacki A; Dobrowolska A; Waszak M; Hnatyszyn PT; Slomski R
    Adv Med Sci; 2019 Mar; 64(1):79-84. PubMed ID: 30553995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?
    van Roon EH; van Puijenbroek M; Middeldorp A; van Eijk R; de Meijer EJ; Erasmus D; Wouters KA; van Engeland M; Oosting J; Hes FJ; Tops CM; van Wezel T; Boer JM; Morreau H
    BMC Cancer; 2010 May; 10():180. PubMed ID: 20444249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Connexin 32 and 43 promoter methylation in Helicobacter pylori-associated gastric tumorigenesis.
    Wang Y; Huang LH; Xu CX; Xiao J; Zhou L; Cao D; Liu XM; Qi Y
    World J Gastroenterol; 2014 Sep; 20(33):11770-9. PubMed ID: 25206281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylation Status of CDH1 Gene in Gastric Biopsy Specimens and Its Association with H. Pylori Infection.
    Hamid KA; Abdalgalil RSA; Mohammed YA; Mahgob R; Mohamedahmed KA; Nour BYM
    Asian Pac J Cancer Prev; 2023 Dec; 24(12):4071-4076. PubMed ID: 38156839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate Stem Cell Antigen Gene Polymorphism Is Associated with
    Tahara T; Tahara S; Horiguchi N; Kato T; Shinkai Y; Okubo M; Terada T; Yoshida D; Funasaka K; Nagasaka M; Nakagawa Y; Kurahashi H; Shibata T; Tsukamoto T; Ohmiya N
    Cancer Prev Res (Phila); 2019 Sep; 12(9):579-584. PubMed ID: 31213476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct methylated profiles in Helicobacter pylori dependent and independent gastric MALT lymphomas.
    Kaneko Y; Sakurai S; Hironaka M; Sato S; Oguni S; Sakuma Y; Sato K; Sugano K; Saito K
    Gut; 2003 May; 52(5):641-6. PubMed ID: 12692046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic Silencing of the MLH1 Promoter in Relation to the Development of Gastric Cancer and its use as a Biomarker for Patients with Microsatellite Instability: a Systematic Analysis.
    Hu G; Qin L; Zhang X; Ye G; Huang T
    Cell Physiol Biochem; 2018; 45(1):148-162. PubMed ID: 29334683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased number of methylated CpG islands correlates with Helicobacter pylori infection, histological and serological severity of chronic gastritis.
    Tahara T; Arisawa T; Shibata T; Nakamura M; Yoshioka D; Okubo M; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Takahama K; Watanabe M; Yamashita H; Hirata I
    Eur J Gastroenterol Hepatol; 2009 Jun; 21(6):613-9. PubMed ID: 19307977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promoter methylation status of MGMT, hMSH2, and hMLH1 and its relationship to corresponding protein expression and TP53 mutations in human esophageal squamous cell carcinoma.
    Su Y; Yin L; Liu R; Sheng J; Yang M; Wang Y; Pan E; Guo W; Pu Y; Zhang J; Liang G
    Med Oncol; 2014 Feb; 31(2):784. PubMed ID: 24366688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation pattern of THBS1, GATA-4, and HIC1 in pediatric and adult patients infected with Helicobacter pylori.
    Alvarez MC; Ladeira MS; Scaletsky IC; Pedrazzoli J; Ribeiro ML
    Dig Dis Sci; 2013 Oct; 58(10):2850-7. PubMed ID: 23765259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the relationship between dietary factors, CagA-positive Helicobacter pylori infection, and RUNX3 promoter hypermethylation in gastric cancer tissue.
    Zhang YW; Eom SY; Yim DH; Song YJ; Yun HY; Park JS; Youn SJ; Kim BS; Kim YD; Kim H
    World J Gastroenterol; 2013 Mar; 19(11):1778-87. PubMed ID: 23555166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression.
    Lu XX; Yu JL; Ying LS; Han J; Wang S; Yu QM; Wang XB; Fang XH; Ling ZQ
    Cancer; 2012 Nov; 118(22):5507-17. PubMed ID: 22576578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
    Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
    Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helicobacter pylori-infection-associated CpG island hypermethylation in the stomach and its possible association with polycomb repressive marks.
    Yoo EJ; Park SY; Cho NY; Kim N; Lee HS; Kang GH
    Virchows Arch; 2008 May; 452(5):515-24. PubMed ID: 18335237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microsatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in Israel.
    Vilkin A; Niv Y; Nagasaka T; Morgenstern S; Levi Z; Fireman Z; Fuerst F; Goel A; Boland CR
    Cancer; 2009 Feb; 115(4):760-9. PubMed ID: 19127559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.